XFOR
X4 Pharmaceuticals, Inc
NASDAQ · Healthcare · Biotechnology · US
$2.75
+6.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.75x
- Price / sales
- 17.21x
- Price / cash flow
- -3.26x
Enterprise value
- Enterprise value
- $141.9M
- EV / sales
- 8.95x
- EV / EBITDA
- -1.78x
- EV / EBIT
- -1.61x
- Market cap
- $272.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026